Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Translational Development Acquisition (TDAC) Other Operating Expenses (2023)

Translational Development Acquisition's Other Operating Expenses history spans 1 years, with the latest figure at $485550.0 for Q4 2023.

  • On a quarterly basis, Other Operating Expenses changed N/A to $485550.0 in Q4 2023 year-over-year; TTM through Dec 2024 was $485550.0, a N/A change, with the full-year FY2023 number at $485550.0, changed N/A from a year prior.
  • Other Operating Expenses came in at $485550.0 for Q4 2023.
  • The five-year high for Other Operating Expenses was $485550.0 in Q4 2023, with the low at $485550.0 in Q4 2023.